Hydromorphone Hydrochloride 87063-0039
Product NDC
87063-0039- Manufacturer
- Asclemed Usa Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- November 23, 2009
- Listing Expires
- December 31, 2026
- Application
- NDA019892
Active Ingredients
| Ingredient | Strength |
|---|---|
| Hydromorphone Hydrochloride | 8 mg/1 |
Drug Class
Full Opioid Agonists [MoA]Opioid Agonist [EPC]
Packaging Options(9)
100 TABLET in 1 BOTTLE, PLASTIC (87063-039-01)
5 TABLET in 1 BOTTLE, PLASTIC (87063-039-05)
7 TABLET in 1 BOTTLE, PLASTIC (87063-039-07)
10 TABLET in 1 BOTTLE, PLASTIC (87063-039-10)
14 TABLET in 1 BOTTLE, PLASTIC (87063-039-14)
20 TABLET in 1 BOTTLE, PLASTIC (87063-039-20)
30 TABLET in 1 BOTTLE, PLASTIC (87063-039-30)
60 TABLET in 1 BOTTLE, PLASTIC (87063-039-60)
90 TABLET in 1 BOTTLE, PLASTIC (87063-039-90)